SciBase Holding AB (publ) (STO:SCIB)

Sweden · Delayed Price · Currency is SEK

0.266

-0.001 (-0.37%)

At close: Mar 6, 2026

-26.92% (1Y)

Market Cap	110.17M
Revenue (ttm)	36.59M
Net Income (ttm)	-90.39M
Shares Out	414.18M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250,301
Average Volume	486,858
Open	0.258
Previous Close	0.267
Day's Range	0.253 - 0.267
52-Week Range	0.185 - 0.598
Beta	0.43
RSI	52.68
Earnings Date	Mar 13, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 38

Stock Exchange Nasdaq Stockholm

Ticker Symbol SCIB

Full Company Profile

Financial Performance

In 2024, SciBase Holding AB's revenue was 29.71 million, an increase of 27.79% compared to the previous year's 23.25 million. Losses were -61.13 million, 9.97% more than in 2023.

Financial Statements

News

There is no news available yet.